154 related articles for article (PubMed ID: 28919785)
1. Biomarker analysis and clinical relevance of TK1 on the cell membrane of Burkitt's lymphoma and acute lymphoblastic leukemia.
Weagel EG; Meng W; Townsend MH; Velazquez EJ; Brog RA; Boyer MW; Weber KS; Robison RA; O'Neill KL
Onco Targets Ther; 2017; 10():4355-4367. PubMed ID: 28919785
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the upregulation and surface expression of hypoxanthine guanine phosphoribosyltransferase in acute lymphoblastic leukemia and Burkitt's B cell lymphoma.
Townsend MH; Ence ZE; Cox TP; Lattin JE; Burrup W; Boyer MK; Piccolo SR; Robison RA; O'Neill KL
Cancer Cell Int; 2020; 20():375. PubMed ID: 32782434
[TBL] [Abstract][Full Text] [Related]
3. Membrane expression of thymidine kinase 1 and potential clinical relevance in lung, breast, and colorectal malignancies.
Weagel EG; Burrup W; Kovtun R; Velazquez EJ; Felsted AM; Townsend MH; Ence ZE; Suh E; Piccolo SR; Weber KS; Robison RA; O'Neill KL
Cancer Cell Int; 2018; 18():135. PubMed ID: 30214377
[TBL] [Abstract][Full Text] [Related]
4. Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker.
Jagarlamudi KK; Shaw M
Biomark Med; 2018 Sep; 12(9):1035-1048. PubMed ID: 30039979
[TBL] [Abstract][Full Text] [Related]
5. Human peripheral gamma delta T cells are stimulated by Daudi Burkitt's lymphoma and not by any other Burkitt's lymphoma tested.
Kaur I; de Jong J; Schell K; Hank J; Fisch P; Sondel PM
Cell Immunol; 1994 Jun; 156(1):54-61. PubMed ID: 8200042
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of equine thymidine kinase 1 and preliminary evaluation of its suitability as a serum biomarker for equine lymphoma.
Wang L; Unger L; Sharif H; Eriksson S; Gerber V; Rönnberg H
BMC Mol Cell Biol; 2021 Dec; 22(1):59. PubMed ID: 34906077
[TBL] [Abstract][Full Text] [Related]
7. Induction of differentiation of African Burkitt's lymphoma cells by phorbol ester: possible relation with early B cells.
Ho YS; Subhendu C; Hsu SM
Cancer Invest; 1987; 5(2):101-7. PubMed ID: 2955857
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
9. Thymidine kinase 1 through the ages: a comprehensive review.
Bitter EE; Townsend MH; Erickson R; Allen C; O'Neill KL
Cell Biosci; 2020 Nov; 10(1):138. PubMed ID: 33292474
[TBL] [Abstract][Full Text] [Related]
10. Novel monoclonal antibodies against thymidine kinase 1 and their potential use for the immunotargeting of lung, breast and colon cancer cells.
Velazquez EJ; Brindley TD; Shrestha G; Bitter EE; Cress JD; Townsend MH; Berges BK; Robison RA; Weber KS; O'Neill KL
Cancer Cell Int; 2020; 20():127. PubMed ID: 32317865
[TBL] [Abstract][Full Text] [Related]
11. Acute lymphoblastic leukemia of Burkitt's type (L3 ALL) with 8;22 and 14;18 translocations and absent surface immunoglobulins.
Gluck WL; Bigner SH; Borowitz MJ; Brenckman WD
Am J Clin Pathol; 1986 May; 85(5):636-40. PubMed ID: 3486584
[TBL] [Abstract][Full Text] [Related]
12. Burkitt's-like lymphoma of T-cell type.
Oliver JD; Grogan TM; Payne CM; Spier C; Richter LC; Rangel CS
Mod Pathol; 1988 Jan; 1(1):15-22. PubMed ID: 3266334
[TBL] [Abstract][Full Text] [Related]
13. Human thymidine kinase 1. Regulation in normal and malignant cells.
Munch-Petersen B; Cloos L; Jensen HK; Tyrsted G
Adv Enzyme Regul; 1995; 35():69-89. PubMed ID: 7572355
[TBL] [Abstract][Full Text] [Related]
14. Calpain inhibitor II induces caspase-dependent apoptosis in human acute lymphoblastic leukemia and non-Hodgkin's lymphoma cells as well as some solid tumor cells.
Zhu DM; Uckun FM
Clin Cancer Res; 2000 Jun; 6(6):2456-63. PubMed ID: 10873099
[TBL] [Abstract][Full Text] [Related]
15. Concanavalin A receptors on the surface membrane of lymphocytes from patients with African Burkitt's lymphoma and lymphoma cell lines.
Ben-Bassat H; Goldblum N; Mitrani S; Klein G; Johansson B
Int J Cancer; 1976 Apr; 17(4):448-54. PubMed ID: 1279037
[TBL] [Abstract][Full Text] [Related]
16. Burkitt's lymphoma presenting as acute leukemia (Burkitt's lymphoma cell leukemia): report of two cases in Israel.
Prokocimer M; Matzner Y; Ben-Bassat H; Polliack A
Cancer; 1980 Jun; 45(11):2884-9. PubMed ID: 6929723
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma.
Mattsson Ulfstedt J; Venge P; Holmgren S; Enblad G; Eriksson S; Molin D
Ups J Med Sci; 2021; 126():. PubMed ID: 34471484
[TBL] [Abstract][Full Text] [Related]
18. Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker.
Jagarlamudi KK; Hansson LO; Eriksson S
BMC Cancer; 2015 Feb; 15():66. PubMed ID: 25881026
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor of DNA binding 4 functions as a tumor suppressor and is targetable by 5-aza-2'-deoxycytosine with potential therapeutic significance in Burkitt's lymphoma.
Gao XZ; Zhao WG; Wang GN; Cui MY; Zhang YR; Li WC
Mol Med Rep; 2016 Feb; 13(2):1269-74. PubMed ID: 26648013
[TBL] [Abstract][Full Text] [Related]
20. Burkitt's lymphoma: clinicopathologic features and differential diagnosis.
Ferry JA
Oncologist; 2006 Apr; 11(4):375-83. PubMed ID: 16614233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
